Literature DB >> 14634393

Genetic profiling of Gleason grade 4/5 prostate cancer: which is the best prostatic control tissue?

Thomas A Stamey1, Mitchell C Caldwell, Zhenbin Fan, Zhaomei Zhang, John E McNeal, Rosalie Nolley, Zuxiong Chen, Mamatha Mahadevappa, Janet A Warrington.   

Abstract

PURPOSE: We examined the variation in gene expression profiles of prostate cancer caused by zone specific genes.
MATERIALS AND METHODS: Ten normal central zone, 10 transition zone (benign prostatic hyperplasia) and 6 normal peripheral zone tissues from radical retropubic prostatectomies were compared to each other and to 12 peripheral zone Gleason grade 4/5 cancers. Test chips and HuGeneFL6800 (Affymetrix, Inc., Santa Clara, California) chips were used to assay the transcribed genes. Data were obtained with the Microarray Suite Version 4.0.1 (Affymetrix, Inc.) and analyzed statistically.
RESULTS: Substantially different gene expression profiles were found depending upon which of the 3 zonal tissues were used as a control. All 3 profiles were compared for efficiency (ability to locate genes) and for robustness (the magnitude of difference between the control and the Gleason grade 4/5 tissue). Microscopically normal appearing peripheral zone tissue at the gene level shows many characteristics of Gleason grade 4/5 cancer.
CONCLUSIONS: Gene expression profiles of prostate cancer are affected by the zonal location of the control tissue and the cancer.

Entities:  

Mesh:

Year:  2003        PMID: 14634393     DOI: 10.1097/01.ju.0000096414.25583.0d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  5 in total

1.  Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.

Authors:  Hongjuan Zhao; Cristiane F Ramos; James D Brooks; Donna M Peehl
Journal:  J Cell Physiol       Date:  2007-01       Impact factor: 6.384

2.  Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.

Authors:  Andrew B Rosenkrantz; Michael J Triolo; Jonathan Melamed; Henry Rusinek; Samir S Taneja; Fang-Ming Deng
Journal:  J Magn Reson Imaging       Date:  2014-02-25       Impact factor: 4.813

Review 3.  Prostate zones and cancer: lost in transition?

Authors:  Amin Ali; Alexander Du Feu; Pedro Oliveira; Ananya Choudhury; Robert G Bristow; Esther Baena
Journal:  Nat Rev Urol       Date:  2021-10-19       Impact factor: 14.432

4.  Identification of candidate prostate cancer genes through comparative expression-profiling of seminal vesicle.

Authors:  Maxwell Thompson; Jacques Lapointe; Yoon-La Choi; David E Ong; John P Higgins; James D Brooks; Jonathan R Pollack
Journal:  Prostate       Date:  2008-08-01       Impact factor: 4.104

5.  Metabolic, pathologic, and genetic analysis of prostate tissues: quantitative evaluation of histopathologic and mRNA integrity after HR-MAS spectroscopy.

Authors:  Carissa F Santos; John Kurhanewicz; Z Laura Tabatabai; Jeffry P Simko; Kayvan R Keshari; Akpene Gbegnon; Romelyn Delos Santos; Scot Federman; Katsuto Shinohara; Peter R Carroll; Christopher M Haqq; Mark G Swanson
Journal:  NMR Biomed       Date:  2009-12-23       Impact factor: 4.044

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.